BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3009725)

  • 1. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
    Phillips GL; Wolff SN; Fay JW; Herzig RH; Lazarus HM; Schold C; Herzig GP
    J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP
    J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
    Buckner JC; Brown LD; Kugler JW; Cascino TL; Krook JE; Mailliard JA; Kardinal CG; Tschetter LK; O'Fallon JR; Scheithauer BW
    J Neurosurg; 1995 Mar; 82(3):430-5. PubMed ID: 7861221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F; Prados M; Russell C; Weissman D; Evans R; Cook P; Burton G; Eisenberg PD; Valenzuela R; Verkh L
    J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
    Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
    Brem H; Ewend MG; Piantadosi S; Greenhoot J; Burger PC; Sisti M
    J Neurooncol; 1995 Nov; 26(2):111-23. PubMed ID: 8787853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ
    Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
    Kessinger A; Lemon HM; Foley JF
    J Surg Oncol; 1978; 10(6):543-7. PubMed ID: 215846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
    Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.
    Burri SH; Prabhu RS; Sumrall AL; Brick W; Blaker BD; Heideman BE; Boltes P; Kelly R; Symanowski JT; Wiggins WF; Ashby L; Norton HJ; Judy K; Asher AL
    J Neurooncol; 2015 Jun; 123(2):259-66. PubMed ID: 25947286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
    Mortimer JE; Hewlett JS; Bay J; Livingston RB
    J Neurooncol; 1983; 1(3):269-73. PubMed ID: 6088718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
    Westphal M; Hilt DC; Bortey E; Delavault P; Olivares R; Warnke PC; Whittle IR; Jääskeläinen J; Ram Z
    Neuro Oncol; 2003 Apr; 5(2):79-88. PubMed ID: 12672279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic expression of O(6)-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O(6)-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea.
    Kreklau EL; Pollok KE; Bailey BJ; Liu N; Hartwell JR; Williams DA; Erickson LC
    Mol Cancer Ther; 2003 Dec; 2(12):1321-9. PubMed ID: 14707273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
    Wolff SN; Phillips GL; Herzig GP
    Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.
    Koç ON; Reese JS; Davis BM; Liu L; Majczenko KJ; Gerson SL
    Hum Gene Ther; 1999 Apr; 10(6):1021-30. PubMed ID: 10223735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
    Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
    J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.